Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure
- 20 February 2002
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 39 (5) , 798-803
- https://doi.org/10.1016/s0735-1097(01)01818-6
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failurePublished by Elsevier ,2004
- Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart FailureNew England Journal of Medicine, 2000
- Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinanAmerican Heart Journal, 2000
- Cost-effectiveness Analysis in Clinical PracticeArchives of internal medicine (1960), 1999
- Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failureJournal of Cardiac Failure, 1998
- Readmission After Hospitalization for Congestive Heart Failure Among Medicare BeneficiariesArchives of internal medicine (1960), 1997
- Hemodynamic and Renal Excretory Effects of Human Brain Natriuretic Peptide Infusion in Patients With Congestive Heart FailureCirculation, 1996
- Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).Circulation, 1993
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991